ANI Pharmaceuticals reported $74.41M in Trade Creditors for its fiscal quarter ending in September of 2026.





Trade Creditors Change Date
AbbVie USD 33.3B 29.71B Jun/2026
ANI Pharmaceuticals USD 74.41M 585K Sep/2026
Aurora Cannabis CAD 56.83M 47.52M Jun/2026
Canopy Growth CAD 28.61M 6.21M Jun/2026
Eli Lilly USD 5.79B 319M Sep/2026
Emergent BioSolutions USD 112.2M 500K Dec/2023
Heron Therapeutics USD 8.38M 3.27M Sep/2026
Hikma Pharmaceutical USD 715M 104M Dec/2025
Knight Therapeutics CAD 125.76M 7.63M Dec/2025
Nektar Therapeutics USD 10.03M 744K Mar/2026
Novartis USD 4.24B 79M Sep/2026
Omeros USD 8.84M 4.42M Jun/2025
Perrigo USD 390.5M 9.9M Sep/2026
Sun Pharmaceuticals INR 74.19B 851.6M Sep/2026
Teva Pharmaceutical Industries USD 2.55B 170M Sep/2026